Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 6.63
(0.45%)
CNY 6.63
(0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.59 Billion | 1.11 Billion | 1.1 Billion | 908 Million | 1.41 Billion | 1.5 Billion |
| Cost of Revenue | 312.47 Million | 247.57 Million | 234.92 Million | 179.85 Million | 251.21 Million | 263.65 Million |
| Gross Profit | 1.28 Billion | 871.27 Million | 865.65 Million | 728.15 Million | 1.16 Billion | 1.23 Billion |
| Operating Expenses | 898.61 Million | 666.85 Million | 732.46 Million | 633.37 Million | 884.37 Million | 931.37 Million |
| Selling, General and Administrative Expenses | 820.43 Million | 573.49 Million | 615.69 Million | 546.67 Million | 781.54 Million | 835.82 Million |
| Research and Development Expenses | 95.87 Million | 52.96 Million | 79.31 Million | 59.11 Million | 54.56 Million | 47.35 Million |
| Other Expenses | 663.4 Thousand | 1.92 Million | 8.69 Million | -1.76 Million | -634.05 Thousand | -226.89 Thousand |
| Cost and Expenses | 1.21 Billion | 914.42 Million | 967.38 Million | 813.22 Million | 1.13 Billion | 1.19 Billion |
| Operating Income | 382.95 Million | 228.36 Million | 171.82 Million | 134.41 Million | 301.84 Million | 274.93 Million |
| Interest Expense | 118.55 Thousand | 127.31 Thousand | 148.49 Thousand | 515.96 Thousand | 151.1 Thousand | 120.78 Thousand |
| Income Tax Expense | 56.63 Million | 36.1 Million | 29.53 Million | 25.48 Million | 50.22 Million | 47.89 Million |
| Earnings before Tax | 388.08 Million | 226.19 Million | 169.65 Million | 131.6 Million | 301.2 Million | 274.7 Million |
| Net Income | 327.87 Million | 190.8 Million | 140.11 Million | 106.12 Million | 250.98 Million | 226.81 Million |
| Earnings Per Share Basic | 0.31 | 0.18 | 0.13 | 0.10 | 0.24 | 0.21 |
| Earnings Per Share Diluted | 0.31 | 0.18 | 0.13 | 0.10 | 0.24 | 0.21 |
| Weighted Average Shares Outstanding | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.05 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.05 Billion |
| Gross Margin | 0.80 | 0.78 | 0.79 | 0.80 | 0.82 | 0.82 |
| EBIT Margin | 0.24 | 0.25 | 0.20 | 0.20 | 0.26 | 0.25 |
| Profit Margin | 0.21 | 0.17 | 0.13 | 0.12 | 0.18 | 0.15 |
| EBITDA | 375.33 Million | 257.9 Million | 203.65 Million | 172.93 Million | 349.29 Million | 326.32 Million |
| Earnings Before Tax Margin | 0.24 | 0.20 | 0.16 | 0.15 | 0.21 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 292.08 Million | 348.43 Million | 475.49 Million | 1.59 Billion | 439.72 Million | 307.98 Million |
| Cost of Revenue | 56.83 Million | 64.32 Million | 88.48 Million | 312.47 Million | 71.74 Million | 59.81 Million |
| Gross Profit | 235.25 Million | 284.1 Million | 387.01 Million | 1.28 Billion | 367.97 Million | 248.16 Million |
| Operating Expenses | 165.93 Million | 231.05 Million | 294.6 Million | 951.56 Million | 239.59 Million | 188.69 Million |
| Selling, General and Administrative Expenses | 236.48 Million | 162.61 Million | 256.74 Million | - | 198.85 Million | 188.33 Million |
| Research and Development Expenses | 26.34 Million | 43.54 Million | 32.38 Million | - | 19.14 Million | 17.3 Million |
| Other Expenses | -96.89 Million | -49.46 Thousand | 1327.43 | 574.74 Thousand | 764.75 Thousand | -51.73 Thousand |
| Cost and Expenses | 222.77 Million | 287.35 Million | 383.08 Million | 1.26 Billion | 311.33 Million | 248.51 Million |
| Operating Income | 87.42 Million | 68.05 Million | 101.14 Million | 382.95 Million | 144.1 Million | 74.97 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 12.58 Million | 14.4 Million | 12.84 Million | 56.63 Million | 13.79 Million | 14.16 Million |
| Earnings before Tax | 87.32 Million | 68 Million | 101.14 Million | 383.53 Million | 144.86 Million | 74.91 Million |
| Net Income | 74.92 Million | 53.68 Million | 88.45 Million | 327.87 Million | 131.74 Million | 60.83 Million |
| Earnings Per Share Basic | 0.07 | 0.05 | 0.08 | - | 0.13 | 0.06 |
| Earnings Per Share Diluted | 0.07 | 0.05 | 0.08 | - | 0.13 | 0.06 |
| Weighted Average Shares Outstanding | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion |
| Gross Margin | 0.81 | 0.82 | 0.81 | 0.80 | 0.84 | 0.81 |
| EBIT Margin | 0.36 | 0.15 | 0.22 | - | 0.32 | 0.18 |
| Profit Margin | 0.26 | 0.15 | 0.19 | 0.21 | 0.30 | 0.20 |
| EBITDA | 105.8 Million | 50.52 Million | 103.03 Million | - | 141.15 Million | 55.07 Million |
| Earnings Before Tax Margin | 0.30 | 0.20 | 0.21 | 0.24 | 0.33 | 0.24 |
AMPLI
0467
0IC7
EXCL
MUR
EMCGU